Health Care & Life Sciences » Pharmaceuticals | Anatara Lifesciences Ltd.

Anatara Lifesciences Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
-
-
2,283.10
322.20
6.50
Cost of Goods Sold (COGS) incl. D&A
-
-
1,570.70
2,330.00
3,104.60
Gross Income
-
-
712.40
2,007.80
3,098.10
SG&A Expense
965.30
1,997.50
1,953.80
2,527.20
2,029.40
EBIT
965.30
1,997.50
1,241.30
4,535.10
5,127.50
Non Operating Income/Expense
90.00
-
-
-
175.50
Pretax Income
862.90
1,856.60
889.20
4,236.60
4,731.60
Income Tax
-
61.40
165.20
2,531.60
1,162.60
Consolidated Net Income
862.90
1,795.20
723.90
1,705.00
3,569.00
Net Income
862.90
1,795.20
723.90
1,705.00
3,569.00
Net Income After Extraordinaries
862.90
1,795.20
723.90
1,705.00
3,569.00
Net Income Available to Common
862.90
1,795.20
723.90
1,705.00
3,569.00
EPS (Basic)
1.89
0.05
0.00
0.03
0.07
Basic Shares Outstanding
37,750.00
33,722.60
48,587.70
49,413.20
49,413.20
EPS (Diluted)
0.02
0.05
0.01
0.03
0.07
Diluted Shares Outstanding
37,750.00
33,722.60
48,587.70
49,413.20
49,413.20
EBITDA
965.30
1,997.50
1,226.20
4,518.10
5,106.40
Non-Operating Interest Income
12.40
140.90
352.10
298.50
220.40

About Anatara Lifesciences

View Profile
Address
433 Logan Road
Brisbane Queensland (QLD) 4120
Australia
Employees -
Website http://www.anataralifesciences.com
Updated 07/08/2019
Anatara Lifesciences Ltd. engages in the development of non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. It also develops and commercializes Detach, a non-antibiotic therapy that prevents and treats diarrhea in piglets. The company was founded by Tracey Mynott on July 15, 2010 and is headquartered in Brisbane, Australia.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.